WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 $US
arrow_upward
+0,48%(+0,060) 1J
16 oct., 16:00:00 UTC−4 · USD
search
Tous les symboles
| Symbole | Cours | Variation | % variat. |
|---|
insights_autoGénération des principaux insights pour WXXWY...
Ouverture
12,29 $US
Élevé
12,56 $US
Faible
12,20 $US
Cap. boursière
198,43 Md
Vol. moyen
61,89 k
Volume
110,85 k
+ haut sur 1 an
14,80 $US
+ bas sur 1 an
7,30 $US
Bêta
0,01
Actions en circulation
2,06 Md
Nombre d'employés
15 k
Ouverture
12,29 $US
Élevé
12,56 $US
Faible
12,20 $US
Cap. boursière
198,43 Md
Vol. moyen
61,89 k
Volume
110,85 k
+ haut sur 1 an
14,80 $US
+ bas sur 1 an
7,30 $US
Bêta
0,01
Actions en circulation
2,06 Md
Nombre d'employés
15 k
Articles
Sources : Web et partenaires du secteur de l'information
Vietnam.vn
·
il y a 1 jour
L'indice S&P 500 a connu son plus fort repli hebdomadaire depuis juin 2026.
Benzinga France
·
il y a 2 jours
Le Dow bondit de plus de 550 points après les données économiques : le sentiment des investisseurs s’améliore, mais l’indice de peur et d’avidité reste en zone de « peur
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
À propos de Wuxi Biologics Cayman ADR